With the earlier definition of chronic obstructive pulmonary disease (COPD), patients were essentially defined as having either chronic bronchitis or emphysema, with emphysema classified as a ...

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...

Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...

New Study Shows Promising Results for COPD Treatment Nov. 20 ... Aug. 23, 2024 — A team of researchers has created a digital pathology platform based on artificial intelligence.

It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

In most cases leftover pathology samples are thrown away Sometimes though they may be used again for other purposes including ...

P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the ...

Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced positive topline results from two ...

John Hood, CEO, Endeavor BioMedicines discusses a potential timeline on availability of ENV-101 for patients with IPF and further validation of the treatment's safety profile.

Belarusian cardiologists work real miracles. What transformations in the medical sector does government support prompt?About fifty ...